Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Clinical trial NCT02172768 · COMPLETED

Trial details

NCT number: NCT02172768
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Graft Versus Host Disease Grade II-IV Allogeneic Stem Cell Transplant Acute Myeloid Leucaemia Myelo Dysplastic Syndrome

Start date: 2014-10-01
Primary completion: 2016-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.